UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
A durable, AI-driven demand backdrop is lifting HPE, Jabil, and CrowdStrike, prompting new targets and optimistic ass...
Rheinmetall posted a quarterly miss that undercut expectations for revenue, net income and margins, triggering a pull...
As markets shift in 2026, four high-yield passive income plays are drawing risk-savvy investors seeking cash flow and...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
A federal judge blocked DOJ subpoenas aimed at Fed Chair Powell over a congressional hearing on the central bank’s HQ...
Bitcoin sits near $71,000 as the rally slows from late-week highs. Behind the calm, a leverage-heavy playbook could t...
As XRP fluctuates in a tight range, traders and analysts scrutinize whether the price prediction: reach $100? is conc...
AI adoption is accelerating, pushing leaders to redefine value beyond raw output. This shift reshapes careers and per...
XRP outperformed broader markets as on-chain activity surged, even as ETF-linked products faced notable outflows. The...
BlackRock CEO Larry Fink warns that AI disruption could raise unemployment among new graduates, even in a steady econ...
Treasury Secretary Scott Bessent declares the United States will not intervene in oil futures despite Iran tensions, ...